Boston Scientific Corporation is an American medical device manufacturer. The company offers solutions for the following medical specialties: electrophysiology, gastroenterology, vascular surgery, gynecology, interventional cardiology, interventional radiology, female pelvic medicine, neurological surgery, orthopedic surgery, pulmology, pain medicine, structural heart, urology.
Market capitalization of Boston Scientific (BSX)
Market cap: NZ$253.90 Billion
As of July 2025 Boston Scientific has a market cap of NZ$253.90 Billion. This makes Boston Scientific the world's 109th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Boston Scientific from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | NZ$253.90 B | 7.17% |
| 2024 | NZ$236.92 B | 76.91% |
| 2023 | NZ$133.91 B | 28.3% |
| 2022 | NZ$104.38 B | 17.78% |
| 2021 | NZ$88.62 B | 25.6% |
| 2020 | NZ$70.56 B | -24.66% |
| 2019 | NZ$93.66 B | 28.39% |
| 2018 | NZ$72.94 B | 52.19% |
| 2017 | NZ$47.93 B | 12.73% |
| 2016 | NZ$42.51 B | 17.19% |
| 2015 | NZ$36.28 B | 61.62% |
| 2014 | NZ$22.44 B | 16.06% |
| 2013 | NZ$19.34 B | 104.82% |
| 2012 | NZ$9.44 B | -6.84% |
| 2011 | NZ$10.13 B | -32.07% |
| 2010 | NZ$14.92 B | -20.29% |
| 2009 | NZ$18.72 B | -6.52% |
| 2008 | NZ$20.02 B | -11.55% |
| 2007 | NZ$22.64 B | -37.28% |
| 2006 | NZ$36.09 B | 22.82% |
| 2005 | NZ$29.39 B | -29.37% |
| 2004 | NZ$41.61 B | -10.93% |
| 2003 | NZ$46.72 B | 39.79% |
| 2002 | NZ$33.42 B | 41.99% |
| 2001 | NZ$23.53 B | 90.59% |
| 2000 | NZ$12.35 B | -27.87% |
| 1999 | NZ$17.12 B | -14.23% |
| 1998 | NZ$19.96 B | 30.3% |
| 1997 | NZ$15.32 B | 1.1% |
| 1996 | NZ$15.15 B |
End of Day market cap according to different sources
On Jul 11th, 2025 the market cap of Boston Scientific was reported to be:
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Edwards Lifesciences EW | NZ$76.13 B | -70.01% | 🇺🇸 USA |
 Stryker Corporation SYK | NZ$247.51 B | -2.52% | 🇺🇸 USA |
 Merit Medical MMSI | NZ$9.18 B | -96.38% | 🇺🇸 USA |
 Medtronic MDT | NZ$191.59 B | -24.54% | 🇮🇪 Ireland |
 Teleflex TFX | NZ$8.55 B | -96.63% | 🇺🇸 USA |
 AngioDynamics ANGO | NZ$0.62 B | -99.75% | 🇺🇸 USA |
 CONMED CNMD | NZ$2.63 B | -98.96% | 🇺🇸 USA |